About
Encora Therapeutics is a medical technology company based in the Boston area, founded in 2021 by Daniel Carballo, Ignacio Mañero, and Andreu Coll. The company specializes in developing non-invasive wearable devices that utilize vibratory stimulus for neuromodulation, specifically targeting upper limb tremors associated with neurological movement disorders like Parkinson’s disease and Essential Tremor. The core product is a wearable device designed to provide on-demand tremor relief without the side effects linked to traditional treatments. This innovative solution combines advances in wearable technology, signal processing, and patient sensing to offer a personalized and affordable approach to managing tremors. Encora Therapeutics is committed to scientific validation, as demonstrated by its rigorous clinical research, including the ULTRE study, which involved a double-blind, randomized trial with 47 patients. The company is also engaged with the FDA’s Breakthrough Device Program to expedite the development of its innovative medical devices.
Technologies
Keywords
Company Information
-
Employees 18
-
Founded 2018
-
Annual Revenue $1000000
-
Total Funding $1500000
Location
Boston, Massachusetts, United States
